Dosage adjustment of methotrexate in a patient with impaired kidney function: Risk of the Bayesian method;Adaptation individuelle de posologie du méthotrexate (MTX) chez un insuffisant rénal sévère: Danger de la méthode Bayésienne

Journal de Pharmacie Clinique

Volumn 20, Issue 4, 2001, Pages 225-228

  Vallee S ^a   Monjanel Mouterde, S ^a   Bagarry Liegey, D ^a   Duffaud, F ^a   Moretto, C ^a   Grabowski, S ^a   Ciccolini, J ^a   Favre, R ^a   Durand, A ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Dosage adjustment; Impaired kidney function; Methotrexate; Pharmacokinetic.; Test dose

Indexed keywords

CREATININE; FOLINIC ACID; HEMOGLOBIN; METHOTREXATE;

ACCURACY; ADULT; ANEMIA; ARTICLE; BAYES THEOREM; CALCULATION; CASE REPORT; CHRONIC KIDNEY FAILURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION; HEMATOCRIT; HUMAN; KIDNEY DYSFUNCTION; LUNG METASTASIS; RISK;

EID: 18344404570     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Methotrexate therapy of head and neck cancer: Improvement in therapeutic index by the use of leucovorin "rescue"
2. Paramètres pharmacocinétiques de population du methotrexate administré à haute dose: Application en pratique clinique de routine
3. High-Dose Methotrexate: A clinical and pharmacokinetic evaluation
4. Methotrexate nephrotoxicity
5. Nonlinear Renal Elimination Kinetics of Methotrexate Due to Saturation of Renal Tubular Reabsorption
6. Apis. A computer program for Clinical Pharmacokinetics
7. Steady-state dosage regimen calculations in linear pharmacokinetics
8. Dynamical dosage regimen calculations in linear pharmacocinetics
9. Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure
10. Dose dependant methotrexate elimination following doses IV injections
11. High-Dose Methotrexate: Preliminary evaluation of a pharmacokinetic approach
12. Effect of Urine pH and Flow on Renal Clearance of Methotrexate
13. Biochemical control of the folinic acid rescue effect after high-dose methotrexate therapy